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Results: The mean age (±SD) of patients was
7.31± 10.65 years, 83% of them being female, and
4 out of 41 (34%) patients were in an active phase of
he disease. ASCA IgG levels signiﬁcantly were correlated
ith sypmtom duration x disease extension score factorial
r = 0.481, p = 0.001), disease duration x disease extension
core factorial (r = 0.468, p = 0.002), and SES-CD (r = 0.480,
= 0.001). No correlations were noted between ASCA
nd CRP levels and clinical activity. On age-sex adjusted
tepwise regression analysis, sypmtom duration, disease
uration, disease extension, and SES-CD entered into
he model, disease extension score was found to be the
nly independent predictor of ASCA IgG levels (R2 = 0.1,
= 0.044).
Conclusion: Although the aetiopathogenesis of inﬂam-
atory bowel disease remains unsolved, a serologic
nti-microbial response exists one of them being ASCA. Dis-
ase and symptom duration, disease extension but clinical
ctivity have signiﬁcant correlations with ASCA levels point-
ng out to the importance of sustained immunological stimuli
s a triggering process. These results might provide new
nsights into the mechanisms of epithelial responses to anti-
ens and ideas for therapies.
oi:10.1016/j.ijid.2010.02.1746
0.006
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Background: The role of perinuclear antineutrophil
ytoplasmic antibodies (pANCA) and anti-Saccharomyces
erevisiae antibodies (ASCA) assessment in inﬂammatory
owel disease (IBD) diagnosis and differentiating is still
mprecise and controversial.
Methods: The aim of the study was to determine the
ccuracy of pANCA and ASCA in patients with speciﬁc intesti-
al inﬂammations, namely UC, CD, GI Behcet (GI-BD), GI
uberculosis (GI-TBC) which are under the same inﬂam-
atory bowel registry, compared to tree control groups;
amely, Celiac disease, irritable bowel syndrome (IBS)
atients and healthy controls (HC). A total of 493 subjects
102 with UC, 63 with CD, 13 with GI BD, 10 with GI Tb, 130
ith IBS, 10 with Celiac disease, and 165 HC) ﬁrstly admitted
o our weekly IBD outpatient practice of a tertiary referral
enter were analyzed regarding pANCA and ASCA Ig A-G via
mmunoﬂuorescent assay (IFA) with commercially available
FA kits (Euroimmune, Lübeck, Germany).
Results: The prevalence of any pANCA or ASCA positiv-
ty and age and sex of patients are summarized in Table 1.
n UC patients the prevalence of pANCA was 42.2%, which
as signiﬁcantly higher than in CD-4.8% (p = 0.000). ASCA
as found signiﬁcantly more often in CD-54% than in UC
(
a
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atients-4.8% (p = 0.000). The prevalence of ASCA in BD
atients-15.4% disclosed a signiﬁcant difference compared
o CD patients (p = 0.014), but the prevalence of ASCA in TBC
atients showed no signiﬁcant difference compared to CD or
D patients.
Table 1: Prevalence of pANCA and ASCA in different sub-
roups.Marked values(p < .05)
pANCA(+) ASCA(+) age male(%)
BS (n = 130) 1(0.8%) 4(3.07%) 40.84(SD 12.69)* 42.3(a)
C (n = 165) 1(0.6%) 7(4.2%) 35.07(SD 10.49)*;** 40(b)
C (n = 102) 43 (42.2%) 11(10.8%) 40.72(SD 13.44)** 50(c)
D (n = 63) 3 (4.8%) 34(54%) 37.56(SD 12.65) 38.1(d)
I-BD (n = 13) 0 2(15.4%) 32.11(SD 8.89) 61(e)
eliac Disease (n = 10) 0 4(40%) 36.77(SD 7.94) 0(a;b;c;d;e;f)
I-TBC (n = 10) 1(10%) 3(30%) (SD 9.96) 70(f)
Conclusion: Our results conﬁrm that in clinical practice
SCA is not speciﬁc enough to be a useful tool in differential
iagnosis of any speciﬁc inﬂammation. However, it may have
ome value in screening of normal population for any bowel
nﬂammation. pANCA may have a better clinical value in the
iscrimination of UC from other intestinal inﬂammations.
oi:10.1016/j.ijid.2010.02.1747
0.007
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Background: Pentamycin is a broad-spectrum polyene
acrolide and the available intravaginal formulation
FemiFect®, 3mg vaginal tablets, Lumavita AG, Basel,
witzerland) is effective in the treatment of vaginal tri-
homoniasis, candidiasis sustained by Candida albicans and
ixed infections (Clin. Ter. 92: 137-142, 1980; Internet Jour-
al of Gynecology and Obstetrics 11(1), 2009). Because
easts other than C. albicans are frequently isolated in
ecurrent or mixed forms of vaginal mycoses, it is impor-
ant to assess the activity of pentamycin against these
pecies, which also exhibit reduced susceptibility to conven-
ional antimycotic drugs. Therefore, the objective of this
tudy was to compare the in-vitro activity of pentamycin
ith that of nystatin, amphotericin B, and ﬂuconazole
gainst strains of nonalbicans candidal species and strains of
accharomyces cerevisiae isolated from medical samples.
Methods: Two collections of clinical isolates included in
otal 40 strains of C. glabrata, 41 strains of C. parapsilo-
is, 30 strains of C. tropicalis, 30 strains of C. krusei and
0 strains of S. cerevisiae. In-vitro susceptibility testing was
erformed using the broth microdilution method developed
y the Clinical and Laboratory Standards Institute (CLSI),
ocument M27-A2. The minimal inhibitory concentration
MIC) of each tested drug was read visually after 24 hours
nd 48 hours of incubation.
Results: The MIC at which 90% of strains of each yeast
pecies were inhibited (MIC90) after 48 hours of incubation
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was 1-4g/ml for pentamycin, 1-2g/ml for nystatin, 0.5-
1g/ml for amphotericin B and 1-32g/ml for ﬂuconazole.
Some strains of C. glabrata and S. cerevisiae, and most
strains of C. krusei were categorized as susceptible-dose
dependent or resistant to ﬂuconazole, according to the CLSI
document (MIC > 8g/ml). At concentrations)4g/ml, pen-
tamycin inhibited completely the growth of 100% of strains
of all species tested, including those strains less susceptible
to ﬂuconazole (MIC range: 16-32g/ml).
Conclusion: Pentamycin exhibited potent in-vitro fungi-
cidal activity against the yeasts that are frequently isolated
in recurrent forms of vaginal mycoses and mixed infections,
like C. glabrata and S. cerevisiae (J. Clin. Microbiol. 43:
2155-62, 2005; Mycoses 49: 471-5, 2006). Pentamycin was
also highly active against the strains of non-albicans candidal
species that were susceptible-dose dependent or resistant to
ﬂuconazole.
doi:10.1016/j.ijid.2010.02.1748
30.008
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Background: Mycotic Keratitis is a suppurative, usually
ulcerative, and sight threatening infection of cornea that
sometimes lead to loss of vision. The peak of incidence
is observed in the tropical and subtropical regions. To
investigate the etiological agent, predisposing factors and
treatment follow up of mycotic keratitis; this study was
undertaken over a period of 2 years in Mashhad.
Methods: In this prospective, cross sectional study,
among 466 individuals suffering from keratitis,65 patients,
highly suspected to mycotic keratitis were examined by
direct fresh smear (KOH 10%) and culture in Mycology Media.
The results were analyzed by SPSS method.
Results: Among 65 clinically suspected individuals, the
results of direct smear and culture of 44 patients were pos-
itive. 21 patients were male (47.1%) and 24 were female
(52.3%). The patients were between 8 to 84 years old. More
than 40% of them were farmers. Trauma was the most com-
mon predisposing factors in more than 47% cases due to
vegetable material.
Molds and Yeasts were isolated from 86.4% and 13.6% of
the samples respectively.Fusarium spp. were the most frequent isolates
(44.4%).Others included Aspergillus spp. (21.8%), Acre-
monium spp. (8.3%), Penicillium spp. (5.6%) and Candida
albicans (13.9%).Tearing and redness were the most com-
n
u
ats e119
on symptoms observed (93.2%). Amphotricin B was used
n patients with Aspergillus and Candida Keratitis, but for
usarium and other molds keratitis, Natamycin was used
or 6 to 12 weeks. In one patient with Fusarium Keratitis,
edical therapy was failed and therapeutic penetrating
eratoplasty was performed. Six months follow up showed
hat prognosis was good in all of the patients.
Conclusion: In relation to the last decade, the incidence
f Mycotic Keratitis is increased in Mashhad. Keratitis due to
he molds is more prevalent than yeast keratitis. Entrance
f foreign body (Plant particles) is the most common predis-
osing factor. However, it needs long term therapy but the
rognosis is good.
oi:10.1016/j.ijid.2010.02.1749
0.009
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Background: Mucormycosis is a frequently lethal invasive
nfection in high risk individuals including transplant recip-
ents and diabetic individuals. Members of these taxa are
ifﬁcult to identify by traditional methods in the clinical
icrobiology laboratory and in vitro differences in antifun-
al susceptibility within the genera have been noted. Today,
omparative sequences based methods are considered the
old standards for rapid, accurate and objective species
dentiﬁcation of fungi. Although the rRNA regions includ-
ng the 18S, ITS, 5.8S and D1-D2 hypervariable region of
he 28S have been evaluated as targets, none have proven
o be useful as a ‘‘universal’’ locus for broad fungal iden-
iﬁcation. Recently, fredricks et al., analyzed a hitherto
nexplored region of the 28S rRNA gene for species iden-
iﬁcation of a wide range of fungal genera. In the present
tudy, we explored the utility of this target region for
peciﬁc and discriminatory identiﬁcation of Mucormycota
enera.
Methods: A total of 100 isolates representing 10 differ-
nt medically important genera of Mucormycota from the
ulture collections of the Centers for Disease Control and
revention (CDC), Atlanta, GA, and the National Center for
gricultural Utilization Research, U.S. Department of Agri-
ulture, Peoria, IL were used in this study. Genomic DNA
as extracted using Qiagen kit and PCR ampliﬁcation and
equencing of the extended 28S rRNA was performed as pre-
iously described. Sequences were aligned using Clustal W
nd distance matrices were generated using the Biolomics
oftware.
Results: PCR products were generated for all the isolates
ested and amplicon size differences were detected among
he genera. Accordingly, large regions of insertion/deletion
ere observed when the sequences were aligned. Distance
atrices and phylogenetic analyses revealed appreciable
ucleotide differences among the genera tested.
Conclusion: In summary, the novel 28S r RNA region eval-
ated in this study was readily amenable to PCR/sequencing
nd revealed genus speciﬁc nucleotide differences, thus
